Advertisement

Ketorolac Use Shortens Hospital Length of Stay After Bariatric Surgery: a Single-Center 5-Year Experience

  • Kamyar Hariri
  • Elizabeth Hechenbleikner
  • Matthew Dong
  • Subhash U. Kini
  • Gustavo Fernandez-Ranvier
  • Daniel M. HerronEmail author
Original Contribution
  • 5 Downloads

Abstract

Introduction

There has been a recent increased interest in the use of non-steroidal anti-inflammatory drugs (NSAIDs) such as ketorolac for post-operative pain management to minimize opioid use and decrease hospital length of stay (LOS). Although NSAID use has been controversial following bariatric surgery due to anecdotal concerns for increased gastric bleeding, the impact of ketorolac as an adjunct to opioids needs further investigation on LOS and post-operative complications like bleeding.

Objective

This study aims to evaluate the impact of post-operative ketorolac use on opioid consumption, LOS, and bleeding risk after bariatric surgery.

Methods

We retrospectively analyzed a prospectively maintained database of all bariatric surgery patients who either underwent sleeve gastrectomy (SG) or Roux-en-Y gastric bypass surgery (RYGB) at a tertiary center between 2011 and 2015. Patients were stratified into 2 groups based on post-operative pain control regimen as follows: (1) ketorolac and opioids and (2) opioids alone.

Results

A total of 1555 patients were identified who underwent either SG (n = 1255) or RYGB (n = 300). The overall LOS was 1.81 ± .059 days for ketorolac-opioid patients vs. 2.09 ± .065 days for opioid-only patients (P < 0.001). Furthermore, the risk of post-operative bleeding was similar between the two groups (P = 0.097).

Conclusion

Patients who received ketorolac as an adjunct to opioids had a significantly shorter LOS compared to opioid-only patients. Additionally, ketorolac use was not associated with increased risk of post-operative bleeding complications. Therefore, if not contraindicated, ketorolac should be considered routinely for post-operative pain control among bariatric surgery patients.

Keywords

Bariatric surgery Ketorolac Opioids Length of stay Bleeding 

Notes

Compliance with Ethical Standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Stephan BC, Parsa FD. Avoiding opioids and their harmful side effects in the postoperative patient: exogenous opioids, endogenous endorphins, wellness, mood, and their relation to postoperative pain. Hawaii J Med Public Health. 2016;75(3):63–7.Google Scholar
  2. 2.
    Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician. 2008;11(2 Suppl):S105–20.Google Scholar
  3. 3.
    Marret E, Kurdi O, Zufferey P, et al. Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials. Anesthesiology. 2005;102(6):1249–60.CrossRefGoogle Scholar
  4. 4.
    Eberson CP, Pacicca DM, Ehrlich MG. The role of ketorolac in decreasing length of stay and narcotic complications in the postoperative pediatric orthopaedic patient. J Pediatr Orthop. 1999;19(5):688–92.Google Scholar
  5. 5.
    Garimella V, Cellini C. Postoperative pain control. Clin Colon Rectal Surg. 2013;26(3):191–6.CrossRefGoogle Scholar
  6. 6.
    Munro HM, Walton SR, Malviya S, et al. Low-dose ketorolac improves analgesia and reduces morphine requirements following posterior spinal fusion in adolescents. Can J Anaesth. 2002;49(5):461–6.CrossRefGoogle Scholar
  7. 7.
    Etches RC, Warriner CB, Badner N, et al. Continuous intravenous administration of ketorolac reduces pain and morphine consumption after total hip or knee arthroplasty. Anesth Analg. 1995;81(6):1175–80.Google Scholar
  8. 8.
    Lowder JL, Shackelford DP, Holbert D, et al. A randomized, controlled trial to compare ketorolac tromethamine versus placebo after cesarean section to reduce pain and narcotic usage. Am J Obstet Gynecol. 2003;189(6):1559–62.CrossRefGoogle Scholar
  9. 9.
    Stephens DM, Richards BG, Schleicher WF, et al. Is ketorolac safe to use in plastic surgery? A critical review. Aesthet Surg J. 2015;35(4):462–6.CrossRefGoogle Scholar
  10. 10.
    Cassinelli EH, Dean CL, Garcia RM, et al. Ketorolac use for postoperative pain management following lumbar decompression surgery: a prospective, randomized, double-blinded, placebo-controlled trial. Spine. 2008;33(12):1313–7.CrossRefGoogle Scholar
  11. 11.
    Power I, Noble DW, Douglas E, et al. Comparison of i.m. ketorolac trometamol and morphine sulphate for pain relief after cholecystectomy. Br J Anaesth. 1990;65(4):448–55.CrossRefGoogle Scholar
  12. 12.
    Jelinek GA. Ketorolac versus morphine for severe pain. BMJ. 2000;321(7271):1236–7.CrossRefGoogle Scholar
  13. 13.
    Forrest JB, Camu F, Greer IA, et al. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth. 2002;88(2):227–33.CrossRefGoogle Scholar
  14. 14.
    Stouten EM, Armbruster S, Houmes RJ, et al. Comparison of ketorolac and morphine for postoperative pain after major surgery. Acta Anaesthesiol Scand. 1992;36(7):716–21.CrossRefGoogle Scholar
  15. 15.
    Richardson MD, Palmeri NO, Williams SA, et al. Routine perioperative ketorolac administration is not associated with hemorrhage in pediatric neurosurgery patients. J Neurosurg Pediatr. 2016;17(1):107–15.CrossRefGoogle Scholar
  16. 16.
    Hassan M, Tuckman HP, Patrick RH, et al. Hospital length of stay and probability of acquiring infection. Intl J Pharm Health Mrkt. 2010;4(4):324–38.CrossRefGoogle Scholar
  17. 17.
    Feldheiser A, Aziz O, Baldini G, et al. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 2016;60(3):289–334.CrossRefGoogle Scholar
  18. 18.
    Carmichael JC, Keller DS, Baldini G, et al. Clinical practice guidelines for enhanced recovery after Colon and Rectal surgery from the American Society of Colon and Rectal Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons. Dis Colon Rectum. 2017;60(8):761–84.CrossRefGoogle Scholar
  19. 19.
    Soffin EM, YaDeau JT. Enhanced recovery after surgery for primary hip and knee arthroplasty: a review of the evidence. Br J Anaesth. 2016;117(suppl_3):iii62–72.CrossRefGoogle Scholar
  20. 20.
    Govindarajan R, Ghosh B, Sathyamoorthy MK, et al. Efficacy of ketorolac in lieu of narcotics in the operative management of laparoscopic surgery for morbid obesity. Surg Obes Relat Dis. 2005;1(6):530–5.CrossRefGoogle Scholar
  21. 21.
    Strom BL, Berlin JA, Kinman JL, et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding: a Postmarketing surveillance study. JAMA. 1996;275(5):376–82.CrossRefGoogle Scholar
  22. 22.
    Gobble RM, Hoang HLT, Kachniarz B, et al. Ketorolac does not increase perioperative bleeding: a meta-analysis of randomized controlled trials. Plast Reconstr Surg. 2014;133(3):741–55.CrossRefGoogle Scholar
  23. 23.
    Greer IA. Effects of ketorolac tromethamine on hemostasis. Pharmacotherapy. 1990;10(6 ( Pt 2)):71S–6S.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Kamyar Hariri
    • 1
  • Elizabeth Hechenbleikner
    • 1
  • Matthew Dong
    • 1
  • Subhash U. Kini
    • 1
  • Gustavo Fernandez-Ranvier
    • 1
  • Daniel M. Herron
    • 1
    Email author
  1. 1.The Garlock Division of General SurgeryIcahn School of Medicine at Mount Sinai HospitalNew YorkUSA

Personalised recommendations